News | News By Subject | News by Disease News By Date | Search News

Gastro-esophageal reflux disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Sucampo (SCMP) to Terminate Development of Cobiprostone for for PPI-Refractory NERD/SGERD After Trial Failure     4/19/2016
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Eisai Inc. (ESALF.PK) Announces FDA Approval for Aciphex Sprinkle     3/28/2013
FDA Approves AstraZeneca PLC (AZN)'s NEXIUM(R) I.V. for the Treatment of Gastroesophageal Reflux Disease with Erosive Esophagitis in Pediatric and Adolescent Patients     5/2/2011
Sun Pharmaceutical Industries Ltd Says U.S. Court Denies Motion on Protonix     7/19/2010
FDA Approves Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s KAPIDEX(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD     2/2/2009
FDA Declines to Approve Santarus Inc. (SNTS)'s OTC Heartburn Drug     1/13/2009
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Heartburn Drug Beats Prevacid in Studies     5/19/2008
Schering-Plough Corporation (SGP) Announces Filing of U.S. Application for OTC ZEGERID(R)     3/11/2008
KOSAN Biosciences, Inc. (KOSN) Announces License Of Motilin Agonist Program To Pfizer Inc. (PFE); Kosan Will Receive Upfront Payment $12.5M; Additional Milestone Payments Up To $250M     12/20/2006
Schering-Plough Corporation (SGP) Enters Licensing Agreement To Market Prescription MiraLAX(R) Over-The-Counter     12/6/2006
AstraZeneca PLC (AZN) Wins FDA Approval For Liquid Nexium     10/24/2006
Santarus Inc. (SNTS) To License Heartburn Drug Rights To Schering-Plough Corporation (SGP); Santarus May Receive Up To $65 Million     10/18/2006

News from Around the Web
Simple Mineral Could Be Cure For Complex Disease     11/11/2016
Popular Acid Reflux Meds May Boost Kidney Disease Risk, Johns Hopkins University Study     10/28/2015
Modern Treatments for GERD Effective at Achieving Long-Term Remission for Most Patients, Nantes University Study     5/18/2011
Popular Heartburn Meds May Boost Fracture Risk, Hallym University Study Finds     5/10/2011
Reflux Drugs Safe in Early Pregnancy, Statens Serum Institut (SSI) Study     11/29/2010
American College of Gastroenterology: Treating GERD Improves Sleep, Performance, Eastern Virginia Medical School Study     10/20/2010
Heartburn Drugs, Plavix Seem Safe to Take Together, Veterans Affairs Boston Healthcare System Study     10/7/2010
Acupuncture May Relieve Acid Reflux Disease Symptoms, University of California, Los Angeles (UCLA) Study     9/17/2010
Yale University Study Shows Zinc Salts Offer Rapid Relief from Gastric Reflux     8/27/2010
A Caution on Antacids for Older Patients, University of Michigan Study     8/12/2010
Unexpected Consequences Of Proton Pump Inhibitor Use In Reflux Disease, Study in Otolaryngology -- Head and Neck Surgery     11/11/2009
Unexpected Consequences Of Proton Pump Inhibitor Use In Reflux Disease     11/2/2009
Treating Reflux Helps Kids With Asthma, West Jefferson Medical Center Study     11/11/2008
Noninvasive Surgery Performed at Mercy Medical Center Effective for Acid Reflux Disease     6/26/2008
Nearly 40 Percent Of GERD Patients Taking PPIs Experience Recurring Symptoms, Harris Interactive Study     5/19/2008

Press Releases
Mederi Therapeutics Inc. Release: Stretta For GERD Receives Strong Grade Recommendation In A New Clinical Spotlight Review Statement From Society of American Gastrointestinal and Endoscopic Surgeons     4/24/2017
First Patients At Vanderbilt University Medical Center Implanted In EndoStim's LESS GERD Clinical Trial For Gastroesophageal Reflux Disease (GERD)     4/20/2017
First Patient At Allegheny Health Network Implanted In EndoStim's LESS GERD Clinical Trial For Gastroesophageal Reflux Disease (GERD)     4/19/2017
Mederi Therapeutics Inc. Release: Landmark Study: Meta-Analysis Of 28 Studies Shows Stretta Therapy For GERD Consistently And Significantly Improves Outcomes     2/27/2017
Mederi Therapeutics Inc. Release: New Study: When Gerd Returns After Reflux Surgery, Patients Experience 10-Years Of Relief From Non-Surgical Stretta Therapy     1/10/2017
First Two Patients At HonorHealth Research Institute Implanted In EndoStim's LESS GERD Clinical Trial For Gastroesophageal Reflux Disease (GERD)     12/20/2016
Mederi Therapeutics Inc.'s Stretta Therapy For GERD Approved In China     12/8/2016
First Two Patients At SurgOne Foregut Institute Implanted In EndoStim's LESS GERD Clinical Trial For Gastroesophageal Reflux Disease (GERD)     12/2/2016
Mederi Therapeutics Inc. Release: Newly Published Case Series: Stretta As A Treatment Option For GERD In The Bariatric Patient     11/22/2016
International Foundation for Functional Gastrointestinal Disorders (IFFGD) Release: GERD Is More Than Simple Heartburn     11/15/2016
EndoGastric Solutions Announces Publication Of Long-Term Data Demonstrating TIF 2.0 Procedure Offers Durable Treatment Of Chronic GERD     9/26/2016
Ajanta Pharma Announces The Approval And Launch Of Omeprazole And Sodium Bicarbonate Capsules     7/19/2016
Perrigo (PRGO) Announces FDA Final Approval And Launch Of The Store Brand Equivalent To Zegerid OTC Capsules     7/18/2016
EndoGastric Solutions Receives Positive Medical Coverage Policy By HCSC For TIF Procedure With Esophyx Device     7/5/2016
Mederi Therapeutics Inc. Release: New Data On Stretta Therapy For GERD Shows 10-Year Effectiveness In Challenging Patient Populations     6/1/2016